<DOC>
	<DOC>NCT00989703</DOC>
	<brief_summary>The purpose of the study is to evaluate the safety and tolerability of multiple increasing oral doses of GLPG0259 compared to placebo. Also, pharmacokinetics (PK) and pharmacodynamics (PD) of GLPG0259 after multiple increasing oral doses, and potential drug-drug interaction with single dose methotrexate will be assessed.</brief_summary>
	<brief_title>GLPG0259 Multiple Ascending Dose and Methotrexate Drug-drug Interaction (DDI) in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Methotrexate</mesh_term>
	<criteria>healthy male, age 1850 years BMI between 1830 kg/mÂ², inclusive. significantly abnormal platelet function or coagulopathy smoking drug or alcohol abuse</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>